Innovations in Viscoelastic Testing with Bob Roda
Aired On: October 14, 2025
Bob Roda, President and CEO of HemoSonics, joins hosts Michael Roberts and Scott Zeitzer to discuss the company’s Quantra® System, a novel, cartridge-based point-of-care viscoelastic testing system. Bob also shares insights into his career in the medtech industry and what he has learned along the way.
Add to Your Queue
Resources
More Episodes
Earlier Detection of Cognitive Disorders with Marc Jones of Altoida
September 16, 2025
Opportunities & Challenges in Healthcare Entrepreneurship with Dr. Bipin Patel
April 15, 2025
New Innovations Impacting Patient Care with Dr. Michael Redler
March 5, 2024
In this Episode
- 00:00 Introduction to HemoSonics and Its Impact
- 03:51 Bob Roda’s Journey in Medtech
- 09:40 Understanding the Quantra Technology
- 20:25 Future Innovations and Impact on Healthcare
Quotes From This Episode
It’s designed to specifically be near patient, or as I like to describe it at the point of need. So if you’re having open heart surgery and you’re in the need for a blood transfusion, in an hour, your entire clinical situation could change dynamically and critically. The ability to have that information, that data, and that clinical decision making support in real time right near the patient allows for better and improved medical decision making.
Bob Roda
That is what drives me every day, because ultimately it could be my father, my mother, my my kids, my wife, my relatives, or my neighbors that will be positively impacted by the work we do.
Bob Roda
I think most companies are data rich and insight poor. And I think that’s really the advantage of pool data, aggregate masses of data and has now been enabled through, whether it’s AI or machine learning, to look for nuances that a human being couldn’t find in the same way that they would’ve trying to just look at charts and read and look at outcomes.
Bob Roda
